Commentary

Podcast

Pharmacy Focus: Psychedelic Pharmacy - Digital Therapeutics in Psychedelic Medicine

David Keene, vice president of Digital Therapeutics at atai Life Sciences, discussed the growth and future of digital therapeutics.

This month, we sat down with David Keene, vice president of Digital Therapeutics at atai Life Sciences, to discuss the growth and future of digital therapeutics.

Related Videos
Trisha Winroth, PharmD, and Ashly McPhillips, PharmD
Caregiver holding elderly man's hand -- Image credit: Chinnapong | stock.adobe.com
Ashley Pugh, PharmD, and Lauren Angelo, PharmD, MBA
Pride flags during pride event -- Image credit: ink drop | stock.adobe.com
Pharmacy Times Public Health Matters Podcast (logo)
selling mental health medication to man at pharmacy | Image Credit: Syda Productions - stock.adobe.com
Therapy session -- Image credit: pressmaster | stock.adobe.com
Image credit: rawpixel.com | stock.adobe.com
Related Content
Mental Health, Stress, Burnout, Pharmacy, Pharmacist | Image Credit: ©Yura Yarema | stock.adobe.com
November 20th 2024

Q&A: Reducing Mental Health Stigma Starts in Pharmacies

Pharmacy Focus: Oncology Edition- Exploring Pelareorep: A Novel Immunotherapy for Advanced Breast Cancer
October 28th 2024

Pharmacy Focus: Oncology Edition- Exploring Pelareorep: A Novel Immunotherapy for Advanced Breast Cancer

Allergic Diseases Potentially Increase Risk of Select Mental Health Conditions
November 14th 2024

Allergic Diseases Potentially Increase Risk of Select Mental Health Conditions

Luke Halpern, Assistant Editor
Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment
September 26th 2024

Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment

FDA Approval, Neurology, AADC Deficiency | Image Credit: Aquir | stock.adobe.com
Published: November 14th 2024 | Updated: November 14th 2024

FDA Approves Eladocagene Exuparvovec-Tneq for Treatment of AADC Deficiency

Ashley Gallagher, Associate Editor
Mental health conditions, schizophrenia diagnosis and treatment with antipsychotic medication and psychotherapy.
November 11th 2024

Lumateperone Demonstrates Positive Efficacy for Schizophrenia Relapse Prevention

Luke Halpern, Assistant Editor